Sources | Names Used |
---|---|
CTRPv2 | UNC0638:navitoclax (1:1 mol/mol) |
PharmacoGx | UNC0638:navitoclax (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KIF5C | CTRPv2 | pan-cancer | AAC | 0.3 | 6e-15 |
mRNA | TUBA1A | CTRPv2 | pan-cancer | AAC | 0.3 | 9e-15 |
mRNA | KCNC1 | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-14 |
mRNA | FAM57B | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-14 |
mRNA | RP3-403A15.5 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-13 |
mRNA | CELF4 | CTRPv2 | pan-cancer | AAC | 0.31 | 6e-17 |
mRNA | WDR7 | CTRPv2 | pan-cancer | AAC | 0.31 | 7e-15 |
mRNA | PRR36 | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-16 |
mRNA | KIAA0408 | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-13 |
mRNA | GPC2 | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-12 |